1.
Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ: Structure and function of the blood-brain barrier. Neurobiology of disease 2010, 37(1):13-25.
2.
Li Z, Mo N, Li L, Cao Y, Wang W, Liang Y, Deng H, Xing R, Yang L, Ni C et al: Surgery-Induced Hippocampal Angiotensin II Elevation Causes Blood-Brain Barrier Disruption
via MMP/TIMP in Aged Rats. Frontiers in cellular neuroscience 2016, 10:105.
3.
Sweeney MD, Sagare AP, Zlokovic BV: Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 2018, 14(3):133-150.
4.
Raja R, Rosenberg GA, Caprihan A: MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies. Neuropharmacology 2018, 134(Pt B):259-271.
5.
Luo D, Zhao J, Rong J: Plant-derived triterpene celastrol ameliorates oxygen glucose deprivation-induced
disruption of endothelial barrier assembly via inducing tight junction proteins. Phytomedicine : international journal of phytotherapy and phytopharmacology 2016, 23(13):1621-1628.
6.
Blanchette M, Daneman R: Formation and maintenance of the BBB. Mechanisms of development 2015, 138 Pt 1:8-16.
7.
Chen JT, Lin YL, Chen TL, Tai YT, Chen CY, Chen RM: Ketamine alleviates bradykinin-induced disruption of the mouse cerebrovascular endothelial
cell-constructed tight junction barrier via a calcium-mediated redistribution of occludin
polymerization. Toxicology 2016, 368-369:142-151.
8.
Maherally Z, Fillmore HL, Tan SL, Tan SF, Jassam SA, Quack FI, Hatherell KE, Pilkington
GJ: Real-time acquisition of transendothelial electrical resistance in an all-human, in
vitro, 3-dimensional, blood-brain barrier model exemplifies tight-junction integrity. FASEB journal : official publication of the Federation of American Societies for Experimental
Biology 2018, 32(1):168-182.
9.
Nathoo N, Jalal H, Natah SS, Zhang Q, Wu Y, Dunn JF: Hypoxia and Inflammation-Induced Disruptions of the Blood-Brain and Blood-Cerebrospinal
Fluid Barriers Assessed Using a Novel T1-Based MRI Method. Acta neurochirurgica Supplement 2016, 121:23-28.
10.
Banks WA, Gray AM, Erickson MA, Salameh TS, Damodarasamy M, Sheibani N, Meabon JS,
Wing EE, Morofuji Y, Cook DG et al: Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase,
oxidative stress, neuroinflammation, and elements of the neurovascular unit. Journal of neuroinflammation 2015, 12:223.
11.
Vutukuri R, Brunkhorst R, Kestner RI, Hansen L, Bouzas NF, Pfeilschifter J, Devraj
K, Pfeilschifter W: Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced
BBB disruption. 2018, 144(2):172-185.
12.
Terrando N, Eriksson LI, Ryu JK, Yang T, Monaco C, Feldmann M, Jonsson Fagerlund M,
Charo IF, Akassoglou K, Maze M: Resolving postoperative neuroinflammation and cognitive decline. Annals of neurology 2011, 70(6):986-995.
13.
Ni Y, Teng T, Li R, Simonyi A, Sun GY, Lee JC: TNFalpha alters occludin and cerebral endothelial permeability: Role of p38MAPK. PLoS One 2017, 12(2):e0170346.
14.
Lu Y, Gu Y, Ding X, Wang J, Chen J: Intracellular Ca2+ homeostasis and JAK1/STAT3 pathway are involved in the protective
effect of propofol on BV2 microglia against hypoxia-induced inflammation and apoptosis. 2017, 12(5):e0178098.
15.
Tian Y, Guo S, Guo Y, Jian L: Anesthetic Propofol Attenuates Apoptosis, Abeta Accumulation, and Inflammation Induced
by Sevoflurane Through NF-kappaB Pathway in Human Neuroglioma Cells. Cellular and molecular neurobiology 2015, 35(6):891-898.
16.
Krueger M, Hartig W, Reichenbach A, Bechmann I, Michalski D: Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural
evidence for disrupting tight junctions. PLoS One 2013, 8(2):e56419.
17.
Liu WY, Wang ZB, Zhang LC, Wei X, Li L: Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator
substances. CNS neuroscience & therapeutics 2012, 18(8):609-615.
18.
Keaney J, Campbell M: The dynamic blood-brain barrier. The FEBS journal 2015, 282(21):4067-4079.
19.
Shen Y, Zhou M, Yan J, Gong Z, Xiao Y, Zhang C, Du P, Chen Y: miR-200b inhibits TNF-alpha-induced IL-8 secretion and tight junction disruption of
intestinal epithelial cells in vitro. Am J Physiol Gastrointest Liver Physiol 2017, 312(2):G123-g132.
20.
Khokhlov AP, Fetisova IG, Chekhonin VP, Malakhovsky VK: The changes in the permeability of the blood-brain barrier when under neurosurgical
intervention. Molecular and chemical neuropathology 1993, 20(3):197-202.
21.
Luo T, Xia Z: A small dose of hydrogen peroxide enhances tumor necrosis factor-alpha toxicity in
inducing human vascular endothelial cell apoptosis: reversal with propofol. Anesthesia and analgesia 2006, 103(1):110-116, table of contents.
22.
Mathy-Hartert M, Deby-Dupont G, Hans P, Deby C, Lamy M: Protective activity of propofol, Diprivan and intralipid against active oxygen species. Mediators of inflammation 1998, 7(5):327-333.
23.
Mancino A, Schioppa T, Larghi P, Pasqualini F, Nebuloni M, Chen IH, Sozzani S, Austyn
JM, Mantovani A, Sica A: Divergent effects of hypoxia on dendritic cell functions. Blood 2008, 112(9):3723-3734.
24.
Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, Sobolewski A,
Condliffe AM, Cowburn AS, Johnson N et al: Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB
activity. J Exp Med 2005, 201(1):105-115.
25.
Kim KW, Lee SJ, Kim JC: TNF-alpha upregulates HIF-1alpha expression in pterygium fibroblasts and enhances
their susceptibility to VEGF independent of hypoxia. Experimental eye research 2017, 164:74-81.
26.
Palazon A, Goldrath AW, Nizet V, Johnson RS: HIF transcription factors, inflammation, and immunity. Immunity 2014, 41(4):518-528.
27.
Engelhardt S, Al-Ahmad AJ, Gassmann M, Ogunshola OO: Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes
through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism. Journal of cellular physiology 2014, 229(8):1096-1105.
28.
Jacob A, Potin S, Saubamea B, Crete D, Scherrmann JM, Curis E, Peyssonnaux C, Decleves
X: Hypoxia interferes with aryl hydrocarbon receptor pathway in hCMEC/D3 human cerebral
microvascular endothelial cells. Journal of neurochemistry 2015, 132(4):373-383.
29.
Wang W, Dentler WL, Borchardt RT: VEGF increases BMEC monolayer permeability by affecting occludin expression and tight
junction assembly. American journal of physiology Heart and circulatory physiology 2001, 280(1):H434-440.
30.
Heinolainen K, Karaman S, D'Amico G, Tammela T, Sormunen R, Eklund L, Alitalo K, Zarkada
G: VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling. Circ Res 2017, 120(9):1414-1425.
31.
Nasir A, Reising LO, Nedderman DM, Fulford AD, Uhlik MT, Benjamin LE, Schade AE, Holzer
TR: Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human
Colorectal Carcinoma. Anticancer research 2016, 36(6):2683-2696.
32.
Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. Endocrine reviews 2004, 25(4):581-611.
33.
Park K, Amano H, Ito Y, Kashiwagi S, Yamazaki Y, Takeda A, Shibuya M, Kitasato H,
Majima M: Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis
in a surgical sponge model. Biomed Pharmacother 2016, 78:140-149.
34.
Zhu G, Huang Q, Zheng W, Huang Y, Hua J, Yang S, Zhuang J, Wang J, Chang J, Xu J et al: LPS Upregulated VEGFR-3 Expression Promote Migration and Invasion in Colorectal Cancer
via a Mechanism of Increased NF-kappaB Binding to the Promoter of VEGFR-3. Cellular physiology and biochemistry : international journal of experimental cellular
physiology, biochemistry, and pharmacology 2016, 39(5):1665-1678.
35.
Allred EN, Dammann O, Fichorova RN, Hooper SR, Hunter SJ, Joseph RM, Kuban K, Leviton
A, O'Shea TM, Scott MN: Systemic Inflammation during the First Postnatal Month and the Risk of Attention Deficit
Hyperactivity Disorder Characteristics among 10 year-old Children Born Extremely Preterm. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune
Pharmacology 2017, 12(3):531-543.
36.
Kurihara T, Westenskow PD, Bravo S, Aguilar E, Friedlander M: Targeted deletion of Vegfa in adult mice induces vision loss. The Journal of clinical investigation 2012, 122(11):4213-4217.
37.
Li X, Padhan N, Sjostrom EO, Roche FP, Testini C, Honkura N, Sainz-Jaspeado M, Gordon
E, Bentley K, Philippides A et al: VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread. 2016, 7:11017.
38.
Giordano A, Romano S, D'Angelillo A, Corcione N, Messina S, Avellino R, Biondi-Zoccai
G, Ferraro P, Romano MF: Tirofiban counteracts endothelial cell apoptosis through the VEGF/VEGFR2/pAkt axis. Vascular pharmacology 2016, 80:67-74.
39.
Lei S, Cheng T, Guo Y, Li C, Zhang W, Zhi F: Somatostatin ameliorates lipopolysaccharide-induced tight junction damage via the
ERK-MAPK pathway in Caco2 cells. European journal of cell biology 2014, 93(7):299-307.
40.
Almalki SG, Agrawal DK: ERK signaling is required for VEGF-A/VEGFR2-induced differentiation of porcine adipose-derived
mesenchymal stem cells into endothelial cells. Stem cell research & therapy 2017, 8(1):113.